Substance
APREPITANT
Global reference: every product and company linked to this substance.
- cas: 170729-80-3
- ncit: C49173
- pubchem_cid: 135413536
- rxnorm: 358255
- unii: 1NF15YR6UY
APONVIE · aprepitant [INN] · APREPITANT [JAN] · APREPITANT [USAN] · Aprepitant [WHO-DD] · CINVANTI · EMEND · L-754,030 · MK-0869 · MK-869 · NSC-748825 · ONO-7436
Revenue by product (3)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| MERCK & COMPANY INC. COMMON STOCK (NEW) | EMEND | Q4 2020 | $30.0M |
| HERON THERAPEUTICS INC. COMMON STOCK | CINVANTI | Q2 2026 | $21.8M |
| HERON THERAPEUTICS INC. COMMON STOCK | APONVIE | Q2 2026 | $4.3M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (4)
- APONVIE · HERON THERAPEUTICS INC. COMMON STOCK
- APREPITANT · VIATRIS INC. COMMON STOCK
- CINVANTI · HERON THERAPEUTICS INC. COMMON STOCK
- EMEND · MERCK & COMPANY INC. COMMON STOCK (NEW)